Flow Traders U.S.’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Flow Traders U.S.’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Buy	21,532 +34	+0.2%	+$8	﹤0.01%	967
2026 Q1	$5K	Buy	+21,498	New	+$8.55K	﹤0.01%	961

Other funds holding SGMO

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Flow Traders U.S.'s SGMO Position: Q2 2026 in Review

Flow Traders U.S. increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 0.16% in Q2 2026, buying an estimated $8 and bringing the position to 21,532 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #967.

Flow Traders U.S. first reported a position in SGMO in Q1 2026 and has held it in 2 quarters since. The position peaked at $5K in Q1 2026. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Flow Traders U.S. held 21,532 shares of SANGAMO THERAPEUTICS INC worth $1K as of Q2 2026.
Flow Traders U.S. bought 34 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $8.
SANGAMO THERAPEUTICS INC made up ﹤0.01% of Flow Traders U.S.'s portfolio in Q2 2026, its #967 holding.
Flow Traders U.S. first reported a position in SANGAMO THERAPEUTICS INC in Q1 2026 and has held it in 2 quarters since.
Flow Traders U.S.'s SANGAMO THERAPEUTICS INC position peaked at $5K in Q1 2026.
6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.